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Case Report
Central line-related bacteraemia due to Tsukamurella
tyrosinosolvens in a haematology patient
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CASEREPORT A48-year-oldfemalepatientwith
asix-yearhistoryofnon-secretorymultiplemyeloma
presentedtohospitalinSeptember2001 havingfelt
generally unwell forthe preceding two weeks. She
livedinanurbanareaandhadlimitedmobility. She
describedfeverswithrigorsonanumberofoccasions
particularly associated with flushing ofa Hickman
line, which had been in situ since July 1999. Her
white cell countwas 2.7x 109/1 andshewas mildly
pancytopaenic following a course of doxombicin
and methylprednisolone, which she had received
four weeks previously. Blood culture taken from
thecentrallinehadgrownGram-positivebacilliand
coagulase-negativestaphylococciinthefirst48hours
frombothaerobicandanaerobicbottlesdrawnfrom
thewhite andredlumens ofthe Hickman line.This
episodewasmanagedinthecommunityasacentral
venouscatheterinfectionwithoralciprofloxacinand
intravenous teicoplanin as empirical therapy. On
reviewtwoweekslater,followingcompletionofthe
10-day course ofantibiotics, the patient continued
to be unwell complaining of general malaise and
furtherrigors.Atthistime,intheabsenceofanyother
source ofinfection, adecisionwasmade to remove
the catheter. She dramatically improved thereafter
without further antimicrobial therapy.
Phenotypic identification of the Gram-positive
organism, (isolate identifier: NIPHL100602/
MK2667), isolated from blood culture was
performed employing the API Corynebacterium
system (Biomerieux, Las Halles, France) and gave
the profile 2150004, which gave an identification
of Rhodococcus sp. (82.9%), followed by
Corynebacterium sp. (12.2%). The isolate grew
aerobically on blood agar at 37°C forming small,
rough, dryyellowishcolonies, 2-5 mmindiameter.
The isolate was noted to have an unusual colonial
morphology, as shown (Figure), resembling
non-aerial hyphae, similarto fungal growth, which
wasausefulphenotypiccharacteristic.Theorganism
was sensitive to erythromycin, clindamycin,
fusidic acid, gentamicin, netilmicin, rifampicin,
teicoplanin and vancomycin, but was resistant to
penicillin, oxacillin, tetracycline, chloramphenicol
and trimethoprim, employing a standard in vitro
antibiotic disk diffusion susceptibility assay.
Given the relatively poorphenotypic identification
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obtained,theisolatewassubsequentlyforwardedfor
molecularidentificationthroughPCRamplification
and direct sequencing ofa large but partial region
of the 16S rRNA gene, corresponding to base
position of approximately 811-1374 of E. coli
ATCC 25922 16S rRNA [GenBank Accession
number X80724]. All DNA isolation procedures
were carried out in accordance with the DNA
contamination management guidelines of Millar
et al. and in a Class II Biological Safety Cabinet
(MicroFlow,England)inaroomphysicallyseparated
from that used to set up nucleic acid amplification
reactionmixes andalso fromthe "post-PCR" room
in order to minimise contamination and hence the
possibility offalse positive results. Bacterial DNA
wasextractedfromtheisolateemployingtheRoche
HighPurity PCRTemplate Preparation Kit (Roche
Ltd.,England)inaccordancewiththemanufacturer's
instructions. Extracted DNA was transferred to a
cleantubeandstoredat-80°CpriortoPCR.Foreach
batch ofextractions, a negative extraction control
containingallreagentsminusisolate,wasperformed.
All reaction mixes were set up in a PCR hood in a
room separate from that used to extract DNA and
the amplification and post-PCR room in order to
minimise contamination. Fifty microlitre reaction
mixes were set up as follows:- 10 mM Tris-HC1,
pH 8.3,50mMKC1,2.5mMMgCl2 200 M(each)
dATP, dCTP, dGTP and dTTP; 1.25U ofTaq DNA
Figure Colonial morphology of Tsukamurella
tyrosinosolvens NIPHL100602/MK2667 cultured
at 37°C Columbia blood agar supplemented with
5%[v/v] defibrinatedhorseblood.Notethefungal-
like hypael appearance of the colonies, which is
characteristic ofthe genus Tsukamurella.
polymerase(Amplitaq;PerkinElmer),0.2gMofthe
appropriate"broad-range"primersPSL2(forward)5'
-AGGATTAGATAC CCT GGTAGT CCA-3'(l)
and P13P3 (reverse.) 5' - AGG CCC GGG AAC
GTATTCAC -3'3 and4,ul ofDNAtemplate.2 Prior
to PCR cycling, sealed tubes containing DNA
template and all PCR reagents were introduced to
the thermal cycler at 96°C to avoid non-specific
annealingduringtheinitialrampstage.Thereaction
mixtures were subjected to the following thermal
cycling parameters in a Perkin Elmer Cetus 2400
thermocycler: 96°Cfor3minfollowedby40cycles
of 96°C for 1 min, 55°C for 1 min, 72°C for 1
min, followed by a final extension at 72°C for 10
min. During each run molecular grade water was
included randomly as several negative controls
and DNA templates from Staphylococcus aureus
was included as a positive control, as appropriate.
Foreachbatch ofextractions, an extraction control
containing all reagents minus bacterial organism,
was performed. Following amplification, aliquots
(15 p1) were removed from each reaction mixture
and examined by electrophoresis (80V, 45 min) in
gelscomposedof2%(w/v) agarose (Gibco,UK) in
TAE buffer (40mM Tris, 20mM acetic acid, 1mM
EDTA,pH8.3),stainedwithethidiumbromide(5jg/
100ml).GelswerevisualisedunderUVillumination
using a gel image analysis system (UVP Products,
England) andallimagesarchivedasdigitalgraphic
(*.bmp) files. Amplicons chosen for automated
sequencing were purified using a QlAquick
PCR purification kit (Qiagen Ltd., UK) eluted in
Tris-HC1 (1OmM, pH 8.5) prior to sequencing,
particularly to remove dNTPS, polymerases, salts
and primers. The amplicon was sequenced on the
ALF II Expressg automated sequencer using the
primerPSLwhichwaslabelledwithCy-5fluorescent
dye (Clarke Stevenson, Oligosynthesis Unit, The
Queen's University of Belfast, UK) and used in
conjunctionwiththeThermoSequenaseFluorescent
LabelledPrimerCycleSequencingKit(Amersham,
UK). The resulting sequence obtained (999 bp)
was compared with those stored in the GenBank
Data system using FASTA alignment software
(http://www.ebi.ac.uk), as well as being deposited
in GenBank (Accession number AY259830). On
BLAST analysis in combination with previously
reportedcriteriausedforinterpretationofpartial 16S
rRNA gene sequences,4 the sequence gave a 100%
identification for Tsukamurella tyrosinosolvens
(GenBankAccessionnumbersAY238514,Y12246,
Y12245 & Y12247) followed by T columbiensis
AF272835 (99% identity), T spumae AY238513
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(99% identity), Tpulmonis X92981 (99% identity)
and T strandjordaeAF283283 (99% identity). The
closest Rhodococcus neighbour was Rhodococcus
opacus (AY027586) which was 95% (958/999
bases) similar.
Inthiscase,thepatientdidnotrespondtointravenous
teicoplanin to which the organism was sensitive
for 10 days, thus necessitating the removal ofthe
central line, as this was believed to be the focus
ofinfection. After removal ofthe line, the patient
showedadramaticresponsewithouttheuseoffurther
antibioticsandcontinuedtoremainwell(withinthe
limitations ofher disease) at 18 months following
the Tsukamurella infection. We were unable to
isolate the coagulase-negative staphylococci orthe
Tsukamurellafromthecentrallinetipandthiscould
be explained by the use ofteicoplanin therapy, to
which the organism was sensitive.
The organism was not identified as Tsukamurella
untilthepatientimproved. Itistherefore important
thatTsukamurellashouldbesuspectedasapossible
pathogen in an immunocompromised patient with
a foreign implant such as a central line. Previous
reports demonstratedthatthere is agoodprognosis
by combining the administration of appropriate
antibiotic therapy with removal of the catheter,
which was the case with ourpatient.5
The genus Tsukamurella, was first described by
Collins etal6 in 1988 followingthereclassification
andfurthermolecularandphenotypiccharactization
ofGordanaaurantiaca,Rhodococcusaurantiacaand
otherrelatedorganisms,includingCorynebacterium
paurometabola which were distinct from the
other mycolic acid-containing actinomycetes. The
genus is phylogenetically related to the genera
Nocardia, Gordonia, Streptomyces, Rhodococcus,
Corynebacterium and Mycobacterium and
taxonomically comprises of at least six described
species, including Tsukamurella inchonensis, T
paurometabola, T pulmonis, T strandjordii, T
tyrosinosolvensandTwratislaviensis. Tsukamurella
infections have emerged over the last decade as
a rare but significant cause of serious infection
in immunocompromised individuals. For a
comprehensivereviewofthese cases, see Schwartz
et al.5 Further to this review, an additional case
of line-related sepsis has been shown,7 as well
as a three case of Tsukamurella conjunctivitis,
which were treated successfully after 10 days
disease, including haematological malignancies,
wherethepatientisimmunocompromisedcombined
withindwellingcatheters areimportantriskfactors
for infection with this genus.5 Therefore patients
with indwelling catheters and haematological
malignancies are susceptible populations for
Tsukamurella infection.
Intravascular catheters have become indispensable
in modem medical care. Their use is expected to
be increased in the near future with improvement
in sophisticated medical care leading to increased
numbersofimmunocompromisedpatients,including
those with a haematological malignancy, needing
indwelling intravascular catheters. The range of
catheter-relatedinfectionvariesfromlocalinsertion
site infection through to metastatic deepseated
infections.
Thisreporthighlightsthebenefitsoftheintegrationof
asequence-basedtypingapproachintheidentification
ofdifficult-to-identifybacterial isolates employing
partial regions ofthe 16S rRNA gene. Continued
routine adoption of such techniques by clinical
diagnostic laboratoriesmayprovebeneficialforthe
correctidentificationofbloodborneinfections,aswell
as forthe correct epidemiological characterization
ofunusual causal agents ofbacteraemia inpatients
with haematological malignancies.
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with polymyxin B-neomycin or chloramphenicol
eyedrops.8 Consensus opinion from a synthesis of
publishedreports indicates thatunderlying serious
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